Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma
Condition(s):PlasmacytomaLast Updated:April 6, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):PlasmacytomaLast Updated:April 6, 2022Terminated
Condition(s):Solitary PlasmacytomaLast Updated:April 29, 2022Recruiting
Condition(s):PlasmacytomaLast Updated:December 23, 2022Active, not recruiting
Condition(s):Solitary Bone PlasmacytomaLast Updated:August 3, 2018Withdrawn
Condition(s):Solitary Osseous PlasmacytomaLast Updated:August 17, 2021Active, not recruiting
Condition(s):Extramedullary PlasmacytomaLast Updated:January 13, 2015Unknown status
Condition(s):Multiple Myeloma; PlasmacytomaLast Updated:April 24, 2017Terminated
Condition(s):Plasmacytoma; Plasmacytoma of Bone; Multiple MyelomaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Plasma Cell TumorsLast Updated:December 11, 2020Recruiting
Condition(s):Multiple Myeloma in Relapse; Plasmacytoma; DaratumumabLast Updated:August 22, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.